Cancer Diagnostic Startup Capio Moves to Wisconsin, Raises $2.9M
Jeff Buchanan | January 5th, 2017
In certain patients who are being treated for cancer, it’s possible for cells to detach from the tumors inside their bodies and begin moving through the bloodstream.
These circulating tumor cells, or CTCs, can help oncologists and other clinicians determine how a disease is progressing, and how effective treatments given to that patient have been.
But getting this information requires capturing CTCs, which is not an easy task, in part because CTCs are so rare. That’s according to Seungpyo Hong, a professor at the University of Wisconsin-Madison School of Pharmacy. He is also the co-founder of Capio Biosciences,